It is important for the federal government to hold states accountable for coronavirus relief spending.
Bernie is Back with More Bad Bills
Sen. Bernie Sanders is at it again with more big government legislation that will hurt pharmaceutical innovation.
States Should Make Telemedicine Measures Permanent
State legislatures should work to make telemedicine permanent for patients even after the coronavirus pandemic.
Taxpayer Alert – A Massive Stimulus Spending Spree Is Being Unleashed
President-elect Biden’s $1.9 trillion COVID-19 “relief” and “stimulus” proposal will unleash a massive spending spree that will waste tens of billions of dollars and fail to stimulate the economy.
PBMs File Complaint Against Unwise HHS Rebate Rule
Introducing more private competition will do far more to lower drugs costs for both beneficiaries and taxpayers.
President Trump’s Occupational Licensing EO Will Create Jobs Across the Country
State and local governments will have to issue a license to those who hold a license for their area of discipline.
Top 21 Issues for States in 2021
As states prepare for their legislative sessions, CAGW suggests states should focus on these 21 critical issues.
New Rules Will Fail to Lower Drug Prices
On Friday, November 20, President Trump announced two interim rules that he claims will lower drug costs in Medicare Parts B and D. That is not accurate.
Gov. Ralph Northam Signs Legislation Extending Telemedicine to Help Virginians
Governor Northam (D) signed two bills which would allow medical services to be provided through telemedicine in Virginia.
Pandemic Spending Demonstrates Disconnect in Pentagon’s Priorities
Pentagon officials used money provided for pandemic preparedness to support local jobs. This should mark the end of further stimulus funding for the Department of Defense.